2m 2m 2m 2m 2m 2m 2m
BGM Grp-A (BGM)
NASDAQ
$0.35+$0.007 (+2.05%)
Price as of Jun 23, 2026 7:36 PM EDT- $10.0MMarket Cap
- -97.47%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BGM Grp-A (BGM)
$0.35+$0.007 (+2.05%)
Annual
Quarterly
09/30/2024 | 09/30/2023 | 09/30/2022 | 09/30/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 25.1M -45.99% | 46.5M -28.35% | 64.9M +13.58% | 57.1M +14.12% | |
Cost of Revenue | 21.0M -53.08% | 44.7M -23.72% | 58.6M +13.93% | 51.5M +21.10% | |
Gross Profit | 4.1M +134.93% | 1.8M -71.87% | 6.2M +10.44% | 5.6M -25.21% | |
Sales and Marketing Expense | 92,904 -36.33% | 145,916 -96.46% | 4.1M +26.91% | 3.3M +19.15% | |
Research and Development Expense | -1.4M +139.50% | -568,470 -53.57% | -1.2M +15,204.30% | -8,000 -85.19% | |
Depreciation and Amortization Expense | 1.2M +8.24% | 1.1M -6.66% | 1.2M +1.95% | 1.2M +8.65% | |
Total Operating Expenses | 2.7M -3.79% | 2.8M -31.36% | 4.1M +26.91% | 3.3M +19.15% | |
Operating Profit | -563,771 -78.40% | -2.6M -224.17% | 2.1M -11.98% | 2.4M -50.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 6,791 -99.45% | |
Interest Expense | -639,511 N/A | N/A N/A | N/A N/A | -57,671 -76.26% | |
Interest Income and Expense and Net | -639,511 N/A | 0 N/A | 0 +100.00% | -50,880 -105.12% | |
Total Nonoperating Income and Expense | -1.6M -70.27% | -5.3M +877.54% | -541,444 -155.52% | 975,232 -1.91% | |
Income before Taxes | -2.1M -72.96% | -7.9M -606.41% | 1.6M -53.60% | 3.4M -42.07% | |
Income Taxes | -619,981 -382.88% | 219,166 +12.80% | 194,302 -23.84% | 255,133 -70.50% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.4M -81.46% | -7.8M -822.64% | 1.1M -65.36% | 3.1M -37.09% | |
Net Income from Continuing Operations Applicable to Common | -2.1M -72.96% | -7.9M -606.41% | 1.6M -53.60% | 3.4M -42.07% | |
Basic EPS and Net Income | -0.20 -9.09% | -0.22 -833.33% | 0.03 -66.67% | 0.09 -47.06% | |
Diluted EPS and Net Income | -0.20 -9.09% | -0.22 -833.33% | 0.03 -66.67% | 0.09 -47.06% | |
Basic Weighted Average Shares | 7.2M -79.79% | 35.8M 0.00% | 35.8M +4.87% | 34.1M +13.63% | |
Diluted Weighted Average Shares | 7.2M -79.79% | 35.8M 0.00% | 35.8M +4.87% | 34.1M +13.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.8M +31.31% | 7.5M -47.79% | 14.3M +36.80% | 10.5M -11.80% | |
Short-Term Investments | 1.0M 0.00% | 1.0M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 10.8M +27.62% | 8.5M -40.81% | 14.3M +36.80% | 10.5M -11.80% | |
Total Current Assets | 29.8M -13.74% | 34.5M +14.91% | 30.0M -25.59% | 40.4M +7.59% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 21.9M -4.90% | 23.0M +10.90% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | 10.2M +11.67% | 9.1M +22.92% | |
Total Long-Term Assets | N/A N/A | 172,911 -98.30% | 10.2M +11.67% | 9.1M +22.92% | |
Total Assets | 53.0M +3.41% | 51.3M -20.56% | 64.5M -14.37% | 75.4M +56.52% | |
Income Taxes Payable | 315,328 +54.95% | 203,498 -75.06% | 815,811 +167.21% | 305,305 -77.93% | |
Total Short-Term Debt | 479,715 -76.15% | 2.0M +20.28% | 1.7M -89.01% | 15.2M +107.04% | |
Total Current Liabilities | 8.8M +31.77% | 6.7M -27.45% | 9.2M -49.49% | 18.2M -1.35% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 24,575 0.00% | 24,575 -66.12% | 72,537 -31.68% | 106,180 -31.81% | |
Total Liabilities | 8.9M +29.01% | 6.9M -27.78% | 9.6M -48.82% | 18.7M -3.20% | |
Retained Earnings | 4.3M -26.24% | 5.9M -61.98% | 15.5M +5.55% | 14.7M +20.47% | |
Total Stockholders Equity | 42.7M -0.11% | 42.8M -19.34% | 53.1M -3.29% | 54.9M +110.20% | |
Total Shares Outstanding | 7.2M -79.79% | 35.8M 0.00% | 35.8M +19.17% | 30.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 544,238 +74.32% | 312,209 -97.53% | 12.7M +3,567.52% | 345,034 -93.20% | |
Capital Expenditures | 240,133 +33.59% | 179,759 -94.44% | 3.2M -7.43% | 3.5M +676.31% | |
Cash from Investing Activities | 983,418 +120.74% | -4.7M +45.52% | -3.3M -86.53% | -24.2M +6,343.17% | |
Dividends Paid | 1.8M 0.00% | 1.8M N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -491,728 -83.17% | -2.9M -50.80% | -5.9M -124.75% | 24.0M +1,020.92% | |
Financials Ratio | |||||
Gross Margin | 16.39% +334.99% | 3.77% -60.75% | 9.60% -2.76% | 9.87% N/A | |
Operating Margin | -2.25% -60.01% | -5.62% -273.29% | 3.24% -22.50% | 4.18% N/A | |
Return on Assets | -2.77% -79.41% | -13.44% -973.00% | 1.54% -69.42% | 5.03% N/A | |
Return on Equity | -3.37% -79.22% | -16.24% -913.63% | 2.00% -74.01% | 7.68% N/A | |
Revenue Growth | -45.99% +62.26% | -28.35% -308.70% | 13.58% -3.84% | 14.12% N/A | |
Current Ratio | 3.39 -34.54% | 5.18 +58.40% | 3.27 +47.31% | 2.22 N/A | |
Cash Ratio | 1.12 -0.35% | 1.12 -28.03% | 1.56 +170.83% | 0.58 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow